In this issue:
Sotagliflozin and major adverse CV events
Automated insulin delivery during first 6 months post partum
Intensive BP control in type 2 diabetes
Long-term outcomes after pancreatic islet transplantation
Impact of bodyweight loss on type 2 diabetes remission
Semaglutide in obese HFPEF and type 2 diabetes according to HbA1c
GLP-1 agonists in renal transplant recipients with diabetes
Finerenone and new-onset diabetes in HF
Younger- vs. later-onset type 2 diabetes
Initial renal changes after SGLT-2 inhibitor initiation: clinical outcomes
Please login below to download this issue (PDF)